Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(13%)
Results Posted
100%(4 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_2
3
38%
Ph early_phase_1
1
13%
Ph not_applicable
1
13%
Ph phase_1
2
25%

Phase Distribution

3

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
Terminated2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 12 (28.6%)
Phase 23 (42.9%)
N/A1 (14.3%)

Trials by Status

unknown113%
completed450%
active_not_recruiting113%
terminated225%

Recent Activity

1 active trials
Showing 5 of 8
active_not_recruitingphase_1

Feasibility of [11C]Acetate-PET in LAM and TSC

NCT05467397
completednot_applicable

Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)

NCT03188835
terminatedphase_2

11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation

NCT02811744
completedearly_phase_1

C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer

NCT02715583
completedphase_1

Multi-Tracer PET Assessment of Primary Brain Tumors

NCT00813566
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05467397Phase 1

Feasibility of [11C]Acetate-PET in LAM and TSC

Active Not Recruiting
NCT03188835Not Applicable

Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)

Completed
NCT02811744Phase 2

11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation

Terminated
NCT02715583Early Phase 1

C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer

Completed
NCT00813566Phase 1

Multi-Tracer PET Assessment of Primary Brain Tumors

Completed
NCT01917136Phase 2

11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension

Completed
NCT01777061

Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan

Unknown
NCT02549755Phase 2

11C-acetate for Treatment Response After Radiotherapy for HCC

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8